Conference
Impact of body mass index (BMI) on treatment outcomes to immune checkpoint blockade (ICB) in metastatic renal cell carcinoma (mRCC).
Abstract
566
Authors
Lalani A-KA; Xie W; Flippot R; Steinharter JA; Harshman LC; McGregor BA; Heng DYC; Choueiri TK
Volume
37
Pagination
pp. 566-566
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2019
DOI
10.1200/jco.2019.37.7_suppl.566
Conference proceedings
Journal of Clinical Oncology
Issue
7_suppl
ISSN
0732-183X